Patents by Inventor David Old

David Old has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED CYCLOPENTANES OR CYCLOPENTANONES AS THERAPEUTIC AGENTS
    Publication number: 20080119560
    Abstract: The compounds disclosed herein are useful for treating glaucoma, ocular hypertension, and baldness.
    Type: Application
    Filed: January 9, 2008
    Publication date: May 22, 2008
    Inventors: David Old, Todd Gac, Vinh Ngo
  • Substituted Cyclopentanes Or Cyclopentanones As Therapeutic Agents
    Publication number: 20080058414
    Abstract: Novel compounds, and therapeutic methods, compositions and medicament related thereto are disclosed herein.
    Type: Application
    Filed: January 10, 2006
    Publication date: March 6, 2008
    Applicant: Allergan, Inc.
    Inventors: David Old, Todd Gac, Vinh Ngo
  • THERAPEUTIC SUBSTITUTED THIAZOLIDINONES, OXAZOLIDINONES, AND RELATED COMPOUNDS
    Publication number: 20080058387
    Abstract: A compound having a structure is disclosed herein. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: August 21, 2007
    Publication date: March 6, 2008
    Inventor: David Old
  • Therapeutic Amides and related Compounds
    Publication number: 20080051374
    Abstract: Disclosed herein is a compound having a structure: Therapeutic methods, compositions, and medicaments relating thereto are also disclosed.
    Type: Application
    Filed: August 8, 2007
    Publication date: February 28, 2008
    Inventors: David Old, Danny Dinh
  • THERAPEUTIC N-ARYL OR N-HETEROARYL PYRAZOLIDINE AND PYRAZOLIDINONE DERIVATIVES
    Publication number: 20080045576
    Abstract: A compound having a structure and therapeutic methods, compositions, and medicaments related thereto are disclosed herein.
    Type: Application
    Filed: August 8, 2007
    Publication date: February 21, 2008
    Inventors: David Old, Danny Dinh
  • THERAPEUTIC LACTAMS
    Publication number: 20080039505
    Abstract: Disclosed herein is a compound having a structure Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: August 9, 2007
    Publication date: February 14, 2008
    Inventors: David Old, Robert Burk
  • Ligands for Metals and Improved Metal-Catalyzed Processes Based Thereon
    Publication number: 20080033171
    Abstract: One aspect of the present invention relates to novel ligands for transition metals. A second aspect of the present invention relates to the use of catalysts comprising these ligands in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions. The subject methods provide improvements in many features of the transition metal-catalyzed reactions, including the range of suitable substrates, reaction conditions, and efficiency.
    Type: Application
    Filed: July 23, 2007
    Publication date: February 7, 2008
    Applicant: Massachusetts Institute of Technology
    Inventors: Stephen Buchwald, David Old, John Wolfe, Michael Palucki, Ken Kamikawa
  • THERAPEUTIC COMPOUNDS
    Publication number: 20080033023
    Abstract: Disclosed herein is a compound having a structure or a pharmaceutically acceptable salt, or a prodrug thereof. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: July 17, 2007
    Publication date: February 7, 2008
    Inventors: David Old, Danny Dinh
  • Therapeutic Substituted Pyrrolidone Compounds
    Publication number: 20080015239
    Abstract: Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof are disclosed herein. Details are provided herein. Compositions, methods, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: November 7, 2005
    Publication date: January 17, 2008
    Inventor: David Old
  • SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS
    Publication number: 20070293551
    Abstract: A compound having the formula or a pharmaceutically acceptable salt or a prodrug thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed.
    Type: Application
    Filed: June 6, 2007
    Publication date: December 20, 2007
    Inventor: David Old
  • Subsitituted Gamma Lactams As Therapeutic Agents
    Publication number: 20070287742
    Abstract: A compound comprising or a pharmaceutically acceptable salt, prodrug, or a metabolite thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed.
    Type: Application
    Filed: March 6, 2006
    Publication date: December 13, 2007
    Applicant: Allergan, Inc.
    Inventors: David Old, Danny Dinh
  • SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS
    Publication number: 20070265330
    Abstract: A compound comprising or a pharmaceutically acceptable salt, prodrug, or a metabolite thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed.
    Type: Application
    Filed: May 24, 2007
    Publication date: November 15, 2007
    Inventors: DAVID OLD, Danny Dinh
  • SUBSTITUTED CYCLOPENTANES OR CYCLOPENTANONES AS THERAPEUTIC AGENTS
    Publication number: 20070265464
    Abstract: Therapeutic compounds, methods, and compositions are disclosed herein.
    Type: Application
    Filed: January 4, 2007
    Publication date: November 15, 2007
    Inventors: David Old, Todd Gac, Vinh Ngo
  • CYCLOPENTANE HEPTAN(ENE)OIC ACID, 2-THIOCARBAMOYLOXY AND 2-CARBAMOYLOXY COMPOUNDS AS THERAPEUTIC AGENTS
    Publication number: 20070219256
    Abstract: The invention relates to the use of cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and carbamoyloxy as therapeutic agents e.g. as ocular hypotensives. The compounds used in accordance with the invention are represented by the following formula I: wherein a wavy segments indicate either the alpha (?) or beta (?) configuration; the dashed bond represents a double bond or a single bond; U, Y, X, R1, Ar, n, x and y are as defined in the specification.
    Type: Application
    Filed: June 5, 2007
    Publication date: September 20, 2007
    Inventors: David Old, Robert Burk
  • Prostaglandin analogs
    Publication number: 20070054893
    Abstract: Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof is disclosed herein. A, X, J, and E are as described herein. These compounds are useful for treating diseases.
    Type: Application
    Filed: May 31, 2005
    Publication date: March 8, 2007
    Inventors: David Old, Danny Dinh, Robert Burk
  • 5-Thiopiperdinyl prostaglandin e analogs
    Publication number: 20060281713
    Abstract: A compound comprising or a pharmaceutically acceptable salt or a prodrug thereof is disclosed herein. Y and R are described in detail herein A compound having an ? chain comprising or a derivative thereof, or a pharmaceutically acceptable salt or a prodrug thereof, is disclosed. Derivatives, salts and prodrugs are identified and described in detail. Methods of treating certain conditions or diseases, and compositions and medicaments related thereto are also contemplated.
    Type: Application
    Filed: May 16, 2005
    Publication date: December 14, 2006
    Inventors: David Old, Danny Dinh
  • Prostaglandin analogs
    Publication number: 20060276461
    Abstract: Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof is disclosed herein. A, X, J, E, and Z are as described herein. These compounds are useful for treating diseases.
    Type: Application
    Filed: June 2, 2005
    Publication date: December 7, 2006
    Inventors: David Old, Danny Dinh
  • Therapeutic substituted beta-lactams
    Publication number: 20060252742
    Abstract: Compounds comprising or pharmaceutically acceptable salts or a prodrugs thereof are disclosed herein; wherein Y, A, X, J, and E are described herein.
    Type: Application
    Filed: March 17, 2006
    Publication date: November 9, 2006
    Inventors: David Old, Danny Dinh, Robert Burk
  • Cyclohexyl prostaglandin analogs as rp4-receptor agonists
    Publication number: 20060247215
    Abstract: The invention relates to the use of novel cyclohexyl analogues of E-type prostaglandins as EP4 agonists, in general, and, in particular as ocular hypotensives. The cyclohexyl analogues used in accordance with the invention are represented by the following formula I: wherein the wavy segments represent ? or ? bond, dashed line represents the presence or absence of a bond W, Y, Z, R, R1, R2 and R3 are as defined in the specification.
    Type: Application
    Filed: August 16, 2004
    Publication date: November 2, 2006
    Inventors: David Old, Robert Burk, Thang Dinh
  • Therapeutic Compounds
    Publication number: 20060205800
    Abstract: A compound having a substituted five or six-membered carbocycle or heterocycle directly bonded to a substituted aryl or heteroaryl ring, wherein said compound has an EC50 value of 20 nM or less at the prostaglandin EP2 receptor according to the cAMP assay. Methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: May 30, 2006
    Publication date: September 14, 2006
    Inventors: Yariv Donde, Robert Burk, David Old